Skip to main content
Log in

LMWHs cost saving for DVT prevention

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Shorr AF, Jackson WL, Weiss BM, Moores LK.Low-molecular weight heparin for deep vein thrombosis prophylaxis in hospitalized medical patients: results from a cost-effectiveness analysis. Blood Coagulation and Fibrinolysis 18: 309-316, No. 4, Jun 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

LMWHs cost saving for DVT prevention. Pharmacoecon. Outcomes News 534, 9 (2007). https://doi.org/10.2165/00151234-200705340-00026

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705340-00026

Keywords

Navigation